Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- CheckyesterdayChange DetectedClinicalTrials.gov’s page release has been updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedReplaced Padua, Italy, 35128 with Padova, Italy, 35128 in the location entry to reflect the correct city name.SummaryDifference0.0%

- Check37 days agoChange DetectedNaples, Italy (80131) was added to the list of study locations and Napoli was replaced with Naples. The page also shows a new Revision: v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.0%

- Check72 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.